Wells Fargo Maintains Overweight on Stryker, Lowers Price Target to $348
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $418 to $348.
Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $418 to $348.